Trial Outcomes & Findings for Adductor Canal Catheter Effectiveness and Safety Study (NCT NCT04639128)

NCT ID: NCT04639128

Last Updated: 2024-04-25

Results Overview

Ordinal 0-to-10 point scale of pain severity Minimum value: 0 Maximum value: 10 Higher scores mean more pain

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

126 participants

Primary outcome timeframe

Second postoperative day

Results posted on

2024-04-25

Participant Flow

Participant milestones

Participant milestones
Measure
No-Device
No placement of an adductor canal catheter
Device
Placement of an adductor canal catheter Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
Overall Study
STARTED
63
63
Overall Study
COMPLETED
60
62
Overall Study
NOT COMPLETED
3
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Adductor Canal Catheter Effectiveness and Safety Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
No-Device
n=63 Participants
No placement of an adductor canal catheter
Device
n=63 Participants
Placement of an adductor canal catheter Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
Total
n=126 Participants
Total of all reporting groups
Age, Continuous
66.3 years
STANDARD_DEVIATION 8.6 • n=5 Participants
66.5 years
STANDARD_DEVIATION 9.3 • n=7 Participants
66.5 years
STANDARD_DEVIATION 8.9 • n=5 Participants
Sex: Female, Male
Female
36 Participants
n=5 Participants
35 Participants
n=7 Participants
71 Participants
n=5 Participants
Sex: Female, Male
Male
27 Participants
n=5 Participants
28 Participants
n=7 Participants
55 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
7 Participants
n=5 Participants
10 Participants
n=7 Participants
17 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
6 Participants
n=5 Participants
11 Participants
n=7 Participants
17 Participants
n=5 Participants
Race (NIH/OMB)
White
44 Participants
n=5 Participants
37 Participants
n=7 Participants
81 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants
n=5 Participants
5 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
United States
63 participants
n=5 Participants
63 participants
n=7 Participants
126 participants
n=5 Participants

PRIMARY outcome

Timeframe: Second postoperative day

Population: Had surgery and able to provide postoperative day-2 pain score

Ordinal 0-to-10 point scale of pain severity Minimum value: 0 Maximum value: 10 Higher scores mean more pain

Outcome measures

Outcome measures
Measure
No-Device
n=60 Participants
No placement of an adductor canal catheter
Device
n=62 Participants
Placement of an adductor canal catheter Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
Pain Numerical Rating Scale
6.38 score on a scale
Standard Error 0.30
5.31 score on a scale
Standard Error 0.32

SECONDARY outcome

Timeframe: 15 postoperative days

Population: Numbers of participants do not equal those of the pain-score analyses due to missing data

Total number of 5mg oxycodone tablets (provided to all patients on discharge) consumed over the 15-day postoperative period as recorded in the daily pain-and-medication postoperative diary

Outcome measures

Outcome measures
Measure
No-Device
n=47 Participants
No placement of an adductor canal catheter
Device
n=46 Participants
Placement of an adductor canal catheter Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
Opioid Consumption in the 15-day Postoperative Period
41.9 5mg oxycodone tablets
Standard Error 4.20
46.0 5mg oxycodone tablets
Standard Error 5.59

Adverse Events

No-Device

Serious events: 3 serious events
Other events: 0 other events
Deaths: 0 deaths

Device

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
No-Device
n=63 participants at risk
No placement of an adductor canal catheter
Device
n=63 participants at risk
Placement of an adductor canal catheter Adductor Canal Catheter: The adductor canal catheter is a medical device that consists of a tunneled catheter connected to an analgesic solution-containing reservoir that slowly infuses the anesthetic over the first 2-3 postoperative days
Nervous system disorders
Vertigo
0.00%
0/63 • 30 days postoperatively
1.6%
1/63 • Number of events 1 • 30 days postoperatively
Gastrointestinal disorders
Small-bowel obstruction
1.6%
1/63 • Number of events 1 • 30 days postoperatively
0.00%
0/63 • 30 days postoperatively
Cardiac disorders
Atrial fibrillation
1.6%
1/63 • Number of events 1 • 30 days postoperatively
0.00%
0/63 • 30 days postoperatively
Skin and subcutaneous tissue disorders
Wound dehiscence
1.6%
1/63 • Number of events 1 • 30 days postoperatively
0.00%
0/63 • 30 days postoperatively

Other adverse events

Adverse event data not reported

Additional Information

Dr. Adrian Hinman

The Permanente Medical Group

Phone: 510-454-7292

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place